Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
ID06865638

Comparing Leak Testing Versus No Leak Testing for Anastomosis in Colorectal Cancer Surgery: A Multicenter Randomized Trial

Led by Nanchong Central Hospital · Updated on 2026-03-31

264

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness of gastroscopy, air, and methylene blue (GAM) leak testing in reducing postoperative complications, especially anastomotic leakage, after colorectal cancer surgery. The study focuses on patients with colorectal cancer undergoing surgery and aims to compare clinical outcomes between those who receive leak testing during surgery and those who do not. The primary outcome is the incidence of anastomotic leaks within 30 days after surgery. Participants are divided into groups based on tumor location (rectal cancer ≤ 5 cm from the anus or colorectal cancer > 5 cm) and whether they received preoperative chemotherapy. Some groups receive intraoperative leak testing after the anastomosis is completed, which involves checking the anastomosis integrity using gastroscopy, warm saline immersion, air filling, and methylene blue injection. Others do not receive leak testing. This randomized, double-blind trial compares these groups to assess the impact of leak testing. During the study, participants are monitored for postoperative complications, especially anastomotic leaks, for 30 days following surgery. Researchers will collect data on the number of patients experiencing leaks and other complications. The study involves follow-up assessments within the first month after surgery to evaluate safety and outcomes. Participation lasts through the surgical treatment and the 30-day postoperative observation period.

CONDITIONS

Brief Title

Efficacy and Safety of Colorectal Anastomotic Leak Testing

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with colorectal cancer by pathology and scheduled for surgery who meet surgical indications
  • Aged between 18 and 85 years
  • American Society of Anesthesiologists (ASA) physical status classification I to III
  • Able to understand and sign informed consent and willing to cooperate throughout the study
Not Eligible

You will not qualify if you...

  • Preoperatively diagnosed anastomotic leak or severe abdominal infections
  • Severe cardiovascular or cerebrovascular diseases preventing surgery
  • Severely impaired liver function (Child-Pugh C or above) or kidney function (creatinine clearance < 30 ml/min)
  • Coagulation disorders that cannot be corrected or unadjustable anticoagulant therapy
  • History of abdominal radiotherapy, multiple abdominal surgeries, or severe abdominal adhesions affecting surgery
  • Other active malignant tumors undergoing treatment
  • Mental illness or cognitive impairment preventing cooperation and follow-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Day of surgery and immediate recovery

Participants undergo colorectal cancer surgery during which an intraoperative leak test may be performed to check the integrity of the anastomosis. This testing involves methods such as gastroscopy observation, saline immersion, air filling, or methylene blue injection.

1 surgical visit (in-person)

Post-operative Follow-up

Duration - 30 days

Participants are monitored for post-operative complications and anastomotic leaks within 30 days after surgery.

Approximately 2 to 3 follow-up visits (in-person)

Trial Site Locations

Total: 1 location

1

Nanchong Central Hospital

Nanchong, Sichuan, China

Actively Recruiting

Loading map...

Research Team

Y

Yunhong Tian, doctor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

8

Similar Trials

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

A Phase 1/2a Study Utilizing 64Cu-LNTH-1363S (64Cu Radiolabe...

Metastatic Sarcoma

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here